Evaluation of MicroRNA-122 as a Biomarker for Chronic Hepatitis C Infection and as a Predictor for Treatment Response to Direct-Acting Antivirals.

Naglaa S Elabd Safaa I TayelMoamena S ElhamoulyShaimaa A HassaneinSamar M KamaleldeenFatma E AhmedMahmoud RizkAbdelnaser A GadallahSoma E AjlanAhmed S Sief

Published in: Hepatic medicine : evidence and research (2021)

The results demonstrated the possible function of microRNA-122 as an indicative tool for distinguishing chronic HCV patients from controls and in the assessment of the therapeutic reaction to DAAs.

Keyphrases

end stage renal disease
newly diagnosed
hepatitis c virus
peritoneal dialysis
prognostic factors
patient reported outcomes
human immunodeficiency virus
liver fibrosis